Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Transvenous Pulmonary Isolation for the Treatment of Atrial Fibrillation: A Prospective Randomized Study Comparing Radiofrequency Energy With Cryoenergy

NCT00773539 is registered in ClinicalTrials.gov with Herz-Zentrums Bad Krozingen as lead sponsor.

NCT NCT00773539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00773539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Transvenous Pulmonary Isolation for the Treatment of Atrial Fibrillation: A Prospective Randomized Study Comparing Radiofrequency Energy With Cryoenergy
Lead sponsor
Herz-Zentrums Bad Krozingen
Phase
Phase 4
Overall status
Unknown status
Start date
July 31, 2008
Completion date
August 31, 2009
Enrollment
78 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation ablation